SCHEMBL5103181

SCHEMBL5103181

Cc1ccc(CCNc2ncc(-c3nc4ccccc4s3)c(CC#N)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
MAPT P10636 4/20 0.43
KDM4E B2RXH2 3/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
POLB P06746 2/20 0.43
S1PR2 O95136 1/20 0.43
GLA P06280 1/20 0.43
HPGD P15428 1/20 0.43
ATM Q13315 1/20 0.43
CDK1 P06493 1/20 0.43
KDR P35968 1/20 0.43
MAPK10 P53779 2/20 0.41
MAPK8 P45983 1/20 0.41
MAPK9 P45984 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5596244 0.91 CDK1 (0.43) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL5096401 0.91 ILK (0.48) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL5103578 0.90 SMN1; SMN2 (0.46) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL5110395 0.86 ALDH1A1 (0.46) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL5596497 0.86 KDM4E (0.42) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL17709604 0.86 MAPK10 (0.56) ALDH1A1NPC1RAB9AKDM4EHPGD
SCHEMBL5138885 0.84 CSNK1D (0.41) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL5100115 0.84 PTGS1 (0.41) NPC1RAB9AMAPTLMNACDK1
SCHEMBL5596747 0.79 CDK1 (0.35) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL5103679 0.78 IRAK4 (0.46) POLBKDRMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7470686-B2 Method of inhibiting the expression and/or the activity of JNK LABORATOIRES SERONO SA (CH) 2008-12-30 US claimed
EP-1696909-B1 BENZOTHIAZOLE DERIVATIVES FOR THE TREATMENT OF DIABETES SERONO LAB (CH) 2007-11-14 EP claimed